Digital Strategies to Advance Help-Seeking Aim 1 and 2

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT06774430
Status
Recruiting

Conditions

  • Clinical High Risk
  • Early Psychosis
  • First Episode Psychosis

Eligibility Criteria

Sex
ALL
Age
12 Years - 29 Years
Healthy Volunteers
Not accepted

Study Details

This proposal aims to establish a Digital Laboratory focused on advancing help-seeking and expediting treatment initiation in youth ages 12-29 who are at Clinical High-Risk (CHR) for developing psychosis. Leveraging the Health Action Process Approach (HAPA) model, this study will identify help-seeking subtypes in 25,000 youth who screen positive for psychosis-risk on Mental Health America's national online screening platform, iteratively develop and test theory and data-driven, personalized strategies to advance help-seeking using Micro-Randomized Trials and a Sequential Multiple Assignment Randomized Trial, identify the most accurate CHR screening threshold in an online environment, and link youth, when indicated, to local clinical care via Accelerating Medicines Partnership - Schizophrenia (AMP-SCZ), a NIH funded national network of CHR programs throughout the US. This academic-industry partnership aims to curate one of the largest datasets of youth with CHR, and to develop effective strategies to enhance early help-seeking, in a population where help-seeking is critical and a significant barrier to care.

Key Dates

Start date
Apr 7, 2025
Status verified
Apr 2026
Primary completion
May 31, 2028
Completion
May 31, 2028

Study Design

Enrollment
25,000 participants (estimated)

Primary Outcome Measure

Aim 1: Proportion of participants in each help-seeking category [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia University Irving Medical CenterNew YorkNew York10032
Michael Birnbaum, MD
212-523-2154

Find similar trials in New York, NY

Related Studies